{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:21:38Z","timestamp":1740162098469,"version":"3.37.3"},"reference-count":19,"publisher":"Georg Thieme Verlag KG","issue":"01","license":[{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP Rep"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Neuroendocrine small cell cervical carcinoma is an aggressive cancer which accounts for approximately 1 to 3% of all cervical neoplasms. Therapy must be altered in pregnancy to optimize maternal\u2013fetal outcomes. A 39-year-old woman presented for a routine prenatal visit and was noted to have a grossly abnormal cervix. Cervical biopsies confirmed small cell carcinoma. At 19 weeks' gestation, chemotherapy was initiated. The patient delivered at 34 weeks' gestation to initiate radiation therapy. Six months later, she was diagnosed with metastatic disease and died from cancer complications. In pregnancy, treatment modalities for small cell cervical carcinoma are based on the patient's gestational age at diagnosis. While aggressive early treatment is preferred, platinum-based chemotherapy can be initiated in the second trimester and radiation therapy delayed until delivery. Small cell cervical carcinoma complicating pregnancy requires aggressive treatment. Chemotherapy in the second trimester with planned delayed radiation therapy, may optimize fetal outcomes.<\/jats:p>","DOI":"10.1055\/s-0043-1777998","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T23:34:25Z","timestamp":1706052865000},"page":"e22-e25","source":"Crossref","is-referenced-by-count":0,"title":["Small Cell Cervical Carcinoma in Pregnancy: Therapeutic Options for an Aggressive Cancer Diagnosis"],"prefix":"10.1055","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1800-9893","authenticated-orcid":false,"given":"Alyssa","family":"Savelli Binsted","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, Virginia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeinab","family":"Kassem","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, Virginia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3472-9815","authenticated-orcid":false,"given":"David","family":"Le","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, Virginia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"de Veciana","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, Virginia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2024,1,23]]},"reference":[{"issue":"06","key":"ref1","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1053\/clon.2000.9194","article-title":"Neuroendocrine small cell carcinoma of the uterine cervix: what disease? What treatment? Report of ten cases and a review of the literature","volume":"12","author":"S Delaloge","year":"2000","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"01","key":"ref2","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ygyno.2011.04.011","article-title":"Neuroendocrine tumors of the gynecologic tract: a Society of Gynecologic Oncology (SGO) clinical document","volume":"122","author":"G J Gardner","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"04","key":"ref3","doi-asserted-by":"crossref","first-page":"e33674","DOI":"10.1371\/journal.pone.0033674","article-title":"Chromogranin A (CgA) as poor prognostic factor in patients with small cell carcinoma of the cervix: results of a retrospective study of 293 patients","volume":"7","author":"L M Liao","year":"2012","journal-title":"PLoS One"},{"issue":"01","key":"ref4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/gyno.2000.6117","article-title":"Neuroendocrine small cell carcinoma of the uterine cervix showing polypoid growth and complicated by pregnancy","volume":"81","author":"M Ohwada","year":"2001","journal-title":"Gynecol Oncol"},{"key":"ref5","first-page":"8028459","article-title":"Small cell neuroendocrine carcinoma of the cervix in pregnancy: a case report and review","author":"L Pan","year":"2019","journal-title":"Case Rep Obstet Gynecol"},{"issue":"03","key":"ref6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.gynor.2012.03.003","article-title":"Neuroendocrine carcinoma of the cervix during pregnancy: a case report","volume":"2","author":"P Teefey","year":"2012","journal-title":"Gynecol Oncol Case Rep"},{"issue":"04","key":"ref7","doi-asserted-by":"crossref","first-page":"347.e1","DOI":"10.1016\/j.ajog.2010.04.019","article-title":"Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients","volume":"203","author":"J G Cohen","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"03","key":"ref8","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ygyno.2013.08.033","article-title":"HER2\/neu gene amplification determines the sensitivity of uterine serous carcinoma cell lines to AZD8055, a novel dual mTORC1\/2 inhibitor","volume":"131","author":"D P English","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"03","key":"ref9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0090-8258(02)00150-6","article-title":"Endocrine tumors of the uterine cervix: incidence, demographics, and survival with comparison to squamous cell carcinoma","volume":"88","author":"M E McCusker","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"01","key":"ref10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/0090-8258(92)90077-v","article-title":"Treatment of small cell carcinoma of the cervix with cisplatin, doxorubicin, and etoposide","volume":"47","author":"M Morris","year":"1992","journal-title":"Gynecol Oncol"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1136\/jclinpath-2011-200274","article-title":"A clinicopathological aspect of primary small-cell carcinoma of the uterine cervix: a single-centre study of 25 cases","volume":"64","author":"J D Li","year":"2011","journal-title":"J Clin Pathol"},{"issue":"08","key":"ref12","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0046-8177(03)00284-3","article-title":"P16 overexpression and human papillomavirus infection in small cell carcinoma of the uterine cervix","volume":"34","author":"N Masumoto","year":"2003","journal-title":"Hum Pathol"},{"issue":"02","key":"ref13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/annonc\/mdm465","article-title":"Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study","volume":"19","author":"J M Lee","year":"2008","journal-title":"Ann Oncol"},{"issue":"07","key":"ref14","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1097\/IGC.0000000000000495","article-title":"Clinical features of neuroendocrine carcinoma of the uterine cervix: a single-institution retrospective review","volume":"25","author":"S Nagao","year":"2015","journal-title":"Int J Gynecol Cancer"},{"volume-title":"Small cell neuroendocrine carcinoma of the cervix","year":"2020","author":"M Leitao","key":"ref15"},{"issue":"01","key":"ref16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1006\/gyno.1998.5104","article-title":"Neuroendocrine small cell uterine cervix cancer in pregnancy: long-term survival following combined therapy","volume":"71","author":"K D Balderston","year":"1998","journal-title":"Gynecol Oncol"},{"issue":"01","key":"ref17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3892\/ol.2014.2668","article-title":"Small cell carcinoma of the uterine cervix in pregnancy: a case report and review of the literature","volume":"9","author":"Q Wang","year":"2015","journal-title":"Oncol Lett"},{"issue":"11","key":"ref18","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1002\/cncr.23935","article-title":"Use of platinum derivatives during pregnancy","volume":"113","author":"O Mir","year":"2008","journal-title":"Cancer"},{"issue":"06","key":"ref19","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1097\/AOG.0b013e318173570b","article-title":"Incidence, mortality, and prognostic factors of small cell carcinoma of the cervix","volume":"111","author":"J Chen","year":"2008","journal-title":"Obstet Gynecol"}],"container-title":["American Journal of Perinatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0043-1777998.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T11:05:25Z","timestamp":1730804725000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0043-1777998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":19,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2024,1,23]]},"published-print":{"date-parts":[[2024,1]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0043-1777998","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2157-6998","2157-7005"],"issn-type":[{"type":"print","value":"2157-6998"},{"type":"electronic","value":"2157-7005"}],"subject":[],"published":{"date-parts":[[2024,1]]}}}